Found: 8
Select item for more details and to access through your institution.
Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.
- Published in:
- Health Technology Assessment, 2024, v. 28, n. 11-15, p. v, doi. 10.3310/RDPA1487
- By:
- Publication type:
- Article
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 8, p. 857, doi. 10.1007/s40273-023-01272-9
- By:
- Publication type:
- Article
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 7, p. 741, doi. 10.1007/s40273-023-01259-6
- By:
- Publication type:
- Article
Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 4, p. 353, doi. 10.1007/s40273-023-01247-w
- By:
- Publication type:
- Article
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 239, doi. 10.1007/s40273-023-01244-z
- By:
- Publication type:
- Article